Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
50.91 USD | +1.80% | +4.84% | -9.62% |
07-16 | Wells Fargo Adjusts Price Target on Nutrien to $66 From $68, Maintains Overweight Rating | MT |
07-15 | Nutrien's Price Target Cut by RBC Capital Markets | MT |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
Strengths
- The company's share price in relation to its net book value makes it look relatively cheap.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
Weaknesses
- According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
- The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
- For the past year, analysts have significantly revised downwards their profit estimates.
Ratings chart - Surperformance
Sector: Agricultural Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-9.62% | 24.75B | - | ||
+16.48% | 981M | - | C+ | |
-38.05% | 604M | - | - | |
-10.87% | 504M | - | ||
+26.92% | 288M | - | - | |
0.00% | 101M | - | - | |
+20.27% | 85.14M | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- NTR Stock
- NTR Stock
- Ratings Nutrien Ltd.